DSP Healthcare Fund - Direct Plan - Growth

  • Scheme Category:  
  • Equity Scheme >  
NAV: ₹ 52.5970 ↓ -0.21%
[as on 13 November, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 40 SMA
  • 500 SMA

Returns

CAGR returns till date

CAGR returns of DSP Healthcare Fund - Direct Plan - Growth and its peers as on 13 November, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
DSP Healthcare Fund - Direct Plan - Growth 20.82% -0.21% 2.23% 6.42% 3.01% 20.18% 21.74% 17.17% 25.61%-
Nippon India Banking & Financial Services Fund - Direct Plan Growth Plan - Growth Option 0.99% -0.62% 2.45% 7.41% 2.7% 2.23% 13.1% 13.13% 14.13% 13.63%
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option 15.8% -0.24% 1.96% 7.8% 2.1% 14.1% 18.56% 15.26% 23.02% 16.29%
Nippon India Power & Infra Fund - Direct Plan Growth Plan - Growth Option 7.3% -0.16% 1.91% 1.63% -4.27% 5.37% 17.2% 18.48% 22.45% 17.66%
DSP Banking & Financial Services Fund - Direct - Growth 7.7% -0.32% 3.23% 7.02% 0.66% 10.85%----
BANDHAN Infrastructure Fund-Direct Plan-Growth 1.15% 0.02% 1.1% 3.82% -2.8% -1.34% 14.94% 14.88% 21.09% 16.11%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns--- 9.49% 81.33% 23.43% -6.08% 39.27% 40.77% -4.93%

Discrete returns (monthly)

MonthJan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026Sep 2026Oct 2026
Returns -5.49% 1.5% -5.03% 7.3% 4.17% 6.5% 2.25% 4.79% -3.05% 0.84%

Returns from spefic dates

DescriptionCAGR returns from 18 Oct 2021 (Nifty 50 2021 high)CAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 16.27% 8.32%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
96.14% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 3.86%

Equity

NameSymbol / ISINSectorWeight %Other links
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology8.74%
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology7.95%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology7.45%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology7.35%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services6.47%
Gland Pharma LimitedGLAND (INE068V01023)Pharmaceuticals & Biotechnology5.98%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology4.15%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology4.08%
Cohance Lifesciences LimitedCOHANCE (INE03QK01018)Pharmaceuticals & Biotechnology3.81%
Manipal Health Enterprises Limited (INE459N01021)Healthcare Services3.70%
Pfizer LimitedPFIZER (INE182A01018)Pharmaceuticals & Biotechnology3.22%
Alembic Pharmaceuticals LimitedAPLLTD (INE901L01018)Pharmaceuticals & Biotechnology3.14%
Kovai Medical Center And Hospital LimitedKOVAI (INE177F01017)Healthcare Services2.80%
Concord Biotech LimitedCONCORDBIO (INE338H01029)Pharmaceuticals & Biotechnology2.77%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services2.44%
Procter & Gamble Health LimitedPGHL (INE199A01012)Pharmaceuticals & Biotechnology2.40%
Thyrocare Technologies LimitedTHYROCARE (INE594H01019)Healthcare Services2.11%
Indoco Remedies LimitedINDOCO (INE873D01024)Pharmaceuticals & Biotechnology2.06%
Unichem Laboratories LimitedUNICHEMLAB (INE351A01035)Pharmaceuticals & Biotechnology1.64%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services1.31%
Nephrocare Health Services LimitedNEPHROPLUS (INE428V01029)Healthcare Services1.13%
ICICI Lombard General Insurance Co LimitedICICIGI (INE765G01017)Insurance0.99%
Aarti Drugs LimitedAARTIDRUGS (INE767A01016)Pharmaceuticals & Biotechnology0.91%
Eris Lifesciences LimitedERIS (INE406M01024)Pharmaceuticals & Biotechnology0.76%
Jupiter Life Line Hospitals Limited (INE682M01020)Healthcare Services0.40%
Laxmi Dental LimitedLAXMIDENTL (INE0WO601020)Healthcare Equipment & Supplies0.14%
Globus Medical Inc (US3795772082)Healthcare Equipment & Supplies5.44%
Intuitive Surgical Inc (US46120E6023)Healthcare Equipment & Supplies1.76%
Abbott Laboratories (US0028241000)Pharmaceuticals & Biotechnology0.87%
Grail Inc (US3847471014)Healthcare Equipment & Supplies0.17%

Debt

NameIsinRatingWeight %Yield
Portfolio data is as on date 31 August, 2026

NAV history

DSP Healthcare Fund - Direct Plan - Growth - 30 days NAV (Net asset value) history

DateNAV% change
13 November, 202652.5970 -0.21%
12 November, 202652.7060 -0.24%
11 November, 202652.8350 0.33%
9 November, 202652.6590 2.35%
6 November, 202651.4520 0.53%
5 November, 202651.1830 -0.73%
4 November, 202651.5580 1.98%
3 November, 202650.5550 0.68%
2 November, 202650.2140 0.42%
30 October, 202650.0020 -0.47%
29 October, 202650.2370 0.51%
28 October, 202649.9840 0.57%
27 October, 202649.6990 2.01%
26 October, 202648.7210 1.13%
23 October, 202648.1780 -0.33%
22 October, 202648.3380 -0.02%
21 October, 202648.3460 -0.01%
19 October, 202648.3510 -0.95%
16 October, 202648.8130 -0.69%
15 October, 202649.1530 0.12%
14 October, 202649.0930 -0.67%
13 October, 202649.4220 0.2%
12 October, 202649.3240 -0.17%
9 October, 202649.4070 0.45%
8 October, 202649.1880 -1.76%
7 October, 202650.0670 -0.14%
6 October, 202650.1380 0.88%
5 October, 202649.7000 -0.19%
1 October, 202649.7950 -0.41%
30 September, 202650.0020

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of DSP Healthcare Fund - Direct Plan - Growth?
    The latest NAV of DSP Healthcare Fund - Direct Plan - Growth is 52.5970 as on 13 November, 2026.
  • What are YTD (year to date) returns of DSP Healthcare Fund - Direct Plan - Growth?
    The YTD (year to date) returns of DSP Healthcare Fund - Direct Plan - Growth are 20.82% as on 13 November, 2026.
  • What are 1 year returns of DSP Healthcare Fund - Direct Plan - Growth?
    The 1 year returns of DSP Healthcare Fund - Direct Plan - Growth are 20.18% as on 13 November, 2026.
  • What are 3 year CAGR returns of DSP Healthcare Fund - Direct Plan - Growth?
    The 3 year annualized returns (CAGR) of DSP Healthcare Fund - Direct Plan - Growth are 21.74% as on 13 November, 2026.
  • What are 5 year CAGR returns of DSP Healthcare Fund - Direct Plan - Growth?
    The 5 year annualized returns (CAGR) of DSP Healthcare Fund - Direct Plan - Growth are 17.17% as on 13 November, 2026.
  • What are top 10 holdings of DSP Healthcare Fund - Direct Plan - Growth?
    Top 10 holdings of DSP Healthcare Fund - Direct Plan - Growth are:
    • IPCA Laboratories Limited
    • Sun Pharmaceutical Industries Limited
    • Sai Life Sciences Limited
    • Cipla Limited
    • Apollo Hospitals Enterprise Limited
    • Gland Pharma Limited
    • Divi's Laboratories Limited
    • Alkem Laboratories Limited
    • Cohance Lifesciences Limited
    • Manipal Health Enterprises Limited
    • Pfizer Limited
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for DSP Healthcare Fund - Direct Plan - Growth?
    DSP Healthcare Fund - Direct Plan - Growth is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.